1. Home
  2. FF vs SCLX Comparison

FF vs SCLX Comparison

Compare FF & SCLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo FutureFuel Corp.  Common shares

FF

FutureFuel Corp. Common shares

HOLD

Current Price

$3.46

Market Cap

141.5M

Sector

Industrials

ML Signal

HOLD

Logo Scilex Holding Company

SCLX

Scilex Holding Company

HOLD

Current Price

$16.80

Market Cap

139.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FF
SCLX
Founded
N/A
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Major Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
141.5M
139.3M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
FF
SCLX
Price
$3.46
$16.80
Analyst Decision
Hold
Analyst Count
0
1
Target Price
N/A
N/A
AVG Volume (30 Days)
204.0K
121.1K
Earning Date
11-10-2025
11-14-2025
Dividend Yield
6.94%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$137,409,000.00
$40,360,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$749.70
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.09
$3.60
52 Week High
$5.78
$34.27

Technical Indicators

Market Signals
Indicator
FF
SCLX
Relative Strength Index (RSI) 52.76 42.34
Support Level $3.15 $18.34
Resistance Level $3.44 $20.62
Average True Range (ATR) 0.11 1.99
MACD 0.03 -0.36
Stochastic Oscillator 92.21 0.29

Price Performance

Historical Comparison
FF
SCLX

About FF FutureFuel Corp. Common shares

FutureFuel Corp makes and sells diversified chemical products, bio-based fuel products, and specialty chemical products. The company is organized into two segments based on product type: biofuels and chemicals. The biofuel segment sells biodiesel and other petroleum products. Its fuels are made from a mix of diesel, vegetable oils, and grease feedstock. The chemicals segment sells products that are used in the production of agricultural chemicals, which include herbicides, coatings, and cleaning products, such as detergents.

About SCLX Scilex Holding Company

Scilex Holding Co is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company's commercial product, ZTlido (lidocaine topical system), is a prescription lidocaine topical product for relieving pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. It is focused on commercializing Gloperba (colchicine USP) an oral solution, a prophylactic treatment for painful gout flares in adults. The Company's three product candidates are SP-102 or SEMDEXA viscous gel formulation of a used corticosteroid for epidural injections, SP-103 a Phase 2, triple-strength formulation of ZTlido, and SP-104, 4.5 mg Delayed Burst Release Low Dose Naltrexone Hydrochloride (DBR-LDN) Capsule.

Share on Social Networks: